Industry & Economy
-
Pharmaceuticals
Indian pharma companies top DMF filings
C.R. Sukumar
|
Aurobindo Pharma Ltd has topped the list of Indian pharma companies with 21 DMF filings.
|
Hyderabad
,
Aug. 22
The Indian pharma industry has filed the largest number of drug master files (DMFs) with the United States Food and Drug Administration (USFDA) during the quarter ended June 2006.
Indian companies accounted for the largest share of 35 per cent in the overall filings of 355 DMF submissions during the quarter under review, according to industry sources.
While there has been a broad-based participation by the Indian pharma companies with 32 companies submitting a total of 97 drug dossiers excluding non-drug filings, the scene was mostly dominated by the mid-sized companies over the domestic industry majors. There has been increased number of filings per product, which, according to the analysts, highlights the competitive pressure.
The Hyderabad-based Aurobindo Pharma Ltd has topped the list of Indian pharma companies with 21 DMF filings, followed by Lupin with nine and Matrix Laboratories with eight. Among the larger pharma companies, Sun Pharma filed six DMFs, Dr Reddy's Laboratories three DMFs, including one from its Mexican facility, and Ranbaxy Laboratories one.
More Stories on :
Pharmaceuticals
Article
E-Mail
::
Comment
::
Syndication
::
Printer Friendly Page
|
